Benzinga | Aug 10, 2020 04:24PM EDT

Arcturus Therapeutics Q2 EPS $(0.55), Inline, Sales $2.32M Miss $3.54M Estimate

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.55) per share which met the analyst consensus estimate. This is a 685.71 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $2.32 million which missed the analyst consensus estimate of $3.54 million by 34.41 percent. This is a 77.13 percent decrease over sales of $10.15 million the same period last year.